Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of allopurinol in preventing cardiovascular morbidity and mortality in patients with chronic kidney disease and hyperuricemia
2007-006994-10Phase 4Terminated
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of allopurinol in chronic kidney disease (CKD), hyperuricemia and cardiac morbidity, sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias. Primary endpoint: Cardiovascular mortality. Started Jan 2008; status: terminated.
02
Drugs
allopurinol
03
Conditions
chronic kidney disease (CKD)hyperuricemiacardiac morbidity
Beyond the preview
Go deeper on 2007-006994-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006994-10.